Herein, in this review, introducing the frequently mutated gene EGFR in tumors and its abnormal activation are mainly focused on, highlighting that epidermal growth factor receptor (EGFR) wild‐type and mutants respond differently to ICBs via tumor‐intrinsic and tumor‐extrinsic manners. Here, EGFR is linked to neoplasm.